Pay in 4 interest-free payments of $2.50 Learn more
Ships within 48 hours · Estimated delivery Aug 4 - Aug 9
Howden's FY2025 non-premium revenue £145m and £2
Metric FY2025 EBITDA (Spain) €220M Free cash flow €45M + $42M Gross bookings (Lite) €320M OCF (Lite) €48M Club subs €18
Kyverna Therapeutics zeroes in on the root causes of autoimmune diseases by targeting the troublesome B cells
Initial investment and adaptation would be key
ONXMAPS PORTER'S FIVE FORCES TEMPLATE RESEARCH B_106 Howden's FY2025 non-premium revenue £145mA Must Have Tool for Decision Makers onxMaps faces moderate supplier power and rising substitute threats as location intelligence demand grows; buyer bargaining looks strong among enterprise customers, while barriers to entry are moderate given data and tech requirements. This brief snapshot only scratches the surface. Unlock the full Porter's Five Forces Analysis to explore onxMaps's competitive dynamics, market pressures, and strategic advantages in
US$ 1300.00
US$ 190.00
US$ 45.99
US$ 64.00
US$ 52.34
US$ 2375.00
